Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study

Takashi Nakano, Kozo Kuribayashi, Masashi Kondo, Masahiro Morise, Yuji Tada, Katsuya Hirano, Morihiko Hayashi, Misa Tanaka, Masataka Hirabayashi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study'. Together they form a unique fingerprint.

Medicine & Life Sciences